-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) shares were up 0.3% during mid-day trading on Wednesday . The company traded as high as $13.08 and last traded at $12.87. Approximately 863,388 shares changed hands during trading, a decline of 74% from the average daily volume of 3,376,665 shares. The stock had previously closed at $12.83.
Mind Medicine (MindMed) Trading Up 0.3%
The stock has a fifty day moving average of $10.84 and a 200-day moving average of $8.71.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- These 3 High-Momentum ETFs Are Riding the Tech Wave
- How to Invest in Biotech Stocks
- Verizon Results Trigger Rebound in High-Yield Stock
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Picks & Shovels: Investing in the Physical Foundation of AI
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
